Lehman David Aaron sold $8K of LUNG
Lehman David Aaron (GENERAL COUNSEL) sold 4,915 shares of Pulmonx Corp (LUNG) at $1.54 on 2026-06-01.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider behavior but does not introduce new company performance, regulatory, or product developments.
Market read
Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a fundamental re-rating.
What to watch
Form 4s often reflect diversification, tax, or pre-planned personal needs; without context on total holdings or prior sales, signal strength is limited.
Background
The filing is an SEC Form 4 insider transaction disclosure for Pulmonx Corp.
Ticker impact
Pulmonx Corp insider (general counsel) sold 4,915 shares in an open-market transaction at $1.54 on 2026-06-01.
Low likelihood of sustained price impact; any reaction is likely limited to near-term sentiment/flow effects.
This is an SEC Form 4 disclosure with transaction size and price, but no accompanying company-specific news (earnings, guidance, trial, deal).
Market effects
Minimal; single-company insider transaction without sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity/compensation-related and not a bearish view, especially with no 10b5-1 plan disclosed.
Key entities
- issuerPulmonx Corp
Subject of the insider transaction disclosure (LUNG).
- insiderLehman David Aaron
General counsel who sold 4,915 shares on 2026-06-01.
